An Ohio \u27Test\u27 Case Could Have Major Impact on Nation’s Fight Against Opioids by James, Jack
Saint Louis University School of Law 
Scholarship Commons 
SLU Law Journal Online 
3-4-2019 
An Ohio 'Test' Case Could Have Major Impact on Nation’s Fight 
Against Opioids 
Jack James 
Follow this and additional works at: https://scholarship.law.slu.edu/lawjournalonline 
 Part of the Law Commons 
 




An Ohio 'Test' Case Could Have Major Impact on Nation’s Fight 
Against Opioids 
 
By Jack James* 
 
History of The Crisis 
 
It is no secret that the United States is in the midst of an Opioid Crisis (the 
“Crisis”). What may surprise some, however, is that the Crisis has actually 
been going on for decades. The problem originated in the late 1990s when 
pharmaceutical companies reassured the medical community that their 
opioid pain relievers were not addictive, which led physicians to prescribe 
them at greater rates.1 Widespread misuse and diversion2 of these 
medications followed as a result, all before it became clear that they could, 
in fact, be highly addictive.3 These harmful practices continued over the 
next twenty years with heroin and synthetic opioids, such as fentanyl, 
contributing to the devastation.4 Today, the Crisis has shown no signs of 
slowing down, with over 130 Americans dying every twenty-four hours 
from opioid overdoses.5 
 
In addition to the immeasurable amount of heartache the Crisis has brought 
families and communities, it has also come with a significant economic cost.  
According to a study conducted by the Centers for Disease Control and 
Prevention, the total economic burden of prescription opioid misuse alone 
in the United States is $78.5 billion annually.6 The public sector bears 
approximately one quarter of this cost in the form of health care, substance 
abuse treatment, and criminal justice costs.7 The question persists: will the 
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1 Opioid Overdose Crisis, National Institute on Drug Abuse, (Revised January, 2019), 
https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis. 
2 The term “diversion,” refers to the transfer of opioids from the individual for whom they 
were prescribed, to others, which is illegal. 
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patterns-182. 








government be forced to pick up the tab for battling the Crisis? Perhaps not. 
Thousands of state and local governments have filed complaints against 
prescription opioid manufacturers, suppliers, and distributors demanding 
compensation for the costs of responding to the Crisis.8 Although the 
timelines for these lawsuits vary, the first cases are set to be heard in 
courtrooms as early as this year.9 
 
The “Test” Case in Ohio 
 
One of the largest opioid cases is set to take place in federal court this 
October in Cleveland, Ohio.10 The case, which is being called one of the most 
complicated legal battles in history, consists of hundreds of lawsuits filed 
by cities and counties from around the country.11 Rather than naming one 
type of industry defendant, this litigation lists several, each playing a 
different role – not only drug makers but also distributors and retailers.12 
The plaintiffs claim that: manufacturers like Purdue Pharma and Johnson 
& Johnson aggressively marketed the pills for years despite knowing about 
the addictive properties; distributors like McKesson and Cardinal Health 
shipped alarming quantities without reporting to the authorities; and 
pharmacy chains like Walgreens and CVS Health looked away while selling 
flag-raising amounts of these medications to individuals.13 The legal 
theories under which the plaintiffs are suing include public nuisance, fraud, 
racketeering and corruption, as well as violations of federal and state laws 
covering controlled substances.14 
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The defendants have pushed back in response to the allegations, claiming 
that the Crisis was caused by a number of factors.15 The defendant 
companies challenge state liability for actions concerning the use of 
prescription opioids marketed and overseen by the Food and Drug 
Administration (the “FDA”), the governing body “specifically authorizing” 
such actions.16 The defendants have also argued that much of the misuse of 
prescription and illicit opioids is attributable to downstream actors who are 
far outside of the companies’ control.17 Finally, manufacturers such as 
Purdue Pharma have changed their marketing strategies by ceasing the 
practice of promoting opioid medications to prescribers.18 Purdue Pharma 
has even started allocating funds to support prescription drug education 
around the country and has run full-page ads in national publications 
outlining these efforts.19 Yet, this has done little to silence the critics. In an 
interview earlier this year, Mike Dewine, the Ohio Attorney General, voiced 
his unenthusiastic impression of these efforts in saying, “They can put as 
many ads as they want out there, but that’s not dealing with the problem.”20 
 
While on paper it may appear that these parties are on a collision course to 
meet at trial, the matter will likely never make it there. During the first 
hearing for the case, U.S. District Judge Dan Polster informed lawyers on 
both sides that he intended to dispense with legal norms such as discovery 
and would not preside over years of “unraveling complicated conspiracy 
theories.”21 He then ordered each side to prepare for settlement discussions 
immediately.22 In the past, drug makers and distributors have refuted 
demands of the plaintiffs in the hopes of either narrowing or defeating the 
 
15 Mann, supra note 8. 
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lawsuits in order to mitigate any settlement costs.23 Aware of this, Judge 
Polster reminded the defendants that if they choose to resist a swift 
settlement in favor of litigation, they could be setting themselves up for an 




With this being one of the first cases of its kind, the implications could be 
significant. Other opioid lawsuits around the country are vastly similar, 
and the outcome of this case will likely serve as a bellwether for how future 
cases could play out.25 If the parties settle as expected, the combined amount 
agreed upon between this case and the lawsuits to follow could reach an 
unprecedented height. Public officials hope for an outcome similar to the 
massive tobacco settlement of 1998 worth nearly $250 billion.26 However, to 
cover the costs of the Crisis, such a settlement could amount to several times 
that.27 In Judge Polster’s words, not a settlement that would “just be moving 
money around,” but one that “would provide meaningful solutions to a 
national crisis.”28 Local and state officials have echoed his sentiment, saying 
that they desperately need that kind of cash settlement to solve the crisis.29 
A settlement worth hundreds of billions of dollars could revolutionize the 
national response, supporting more drug rehab programs, detox beds, and 
training for first responders.30 
 
Unfortunately, such a settlement does not appear imminent.31 Even if the 
parties were to enter into any major agreements, Purdue Pharma and other 
defendants are expected to demand that they would not be liable for any 
actions predating the settlement.32 This provision is crucial to the companies 
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because if there is an “escape hatch” in the agreement, the companies are 
presumably paying billions of dollars to be sued again later on.33 Still, with 
the exception of the defendants, most people are hopeful that settlements 
come sooner rather than later.34 Dr. Jeff Gordon, a former president of the 
Connecticut State Medical Society, affirmed this notion in a recent 
interview: “The reality is these lawsuits take years, and years is not 
something we have. We need to deal with this problem now.”35 
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34 Id. 
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